Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease · 5 authors, 4 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
In a cross-sectional simulation study of 244 primary care physicians and cardiologists managing 723 simulated type 2 diabetes patients, only 38.9% correctly calculated cardiovascular risk, and appropriate-intensity statin treatment was provided in only 20.5% of cases.
This cross-sectional study enrolled 161 primary care physicians and 80 cardiologists who evaluated 723 standardized simulated patients with type 2 diabetes between March and June 2022. The primary outcome was variation in cardiovascular risk assessment accuracy and subsequent treatment decisions. Overall quality-of-care scores averaged 49.4±12.6%, ranging from 13% to 84%. Only 38.9% of participants correctly stratified cardiovascular risk; 18.3% did not assess risk at all, and 42.8% stratified incorrectly. Appropriate-intensity statins were prescribed in only 20.5% of cases, and SGLT2 inhibitors or GLP-1 RAs were used when needed in 38.1% of cases. Limitations include the use of simulated rather than actual patients, restriction to asymptomatic outpatient scenarios, and exclusion of endocrinologists and nephrologists.
